Key result
Left atrial appendage occlusion is cost-effective in Sweden for patients who are unable to tolerate oral anticoagulants.
Why the study?
Is left atrial appendage occlusion cost-effective in patients unable to tolerate oral anticoagulants?
Is left atrial appendage occlusion cost-effective in patients unable to tolerate oral anticoagulants?
LAAO is considered cost-effective in Sweden for patients who cannot tolerate oral anticoagulation, though generalizability remains a question.
Cost-effectiveness of left atrial appendage occlusion (LAAO) in patients unable to tolerate oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Sandhu et al. (2022) studied this question. Left atrial appendage occlusion is cost-effective in Sweden for patients who are unable to tolerate oral anticoagulants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: